T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation

Abstract

Magnetic resonance imaging (MRI) is increasingly being used as a monitoring tool for disease activity in therapeutic trials in multiple sclerosis. There is, however, only a limited relationship between MRI findings and clinical outcome measurements. It has been suggested that hypointense lesion load on T1 weighted imaging has a better correlation with disability than the more conventional T2 hyper intense lesion load. This study was undertaken to (i) evaluate different measurement techniques used to quantify T1 hypointense lesion load, and (ii) to compare lesion load as measured using different parameters and disability. Twenty-five patients with secondary progressive multiple sclerosis, mean age of 40 years (23-57), mean EDSS 5.7 (4-7) were analysed. T2 lesion load on FSE correlated well with both the hypointense lesion load on T1 pre-gadolinium (r=0.8, P50.0001) and T1 post-gadolinium (r=0.8, P50.0001) but less so with the enhancing lesion load (r=0.4, P50.05). There was a very strong correlation with T1 hypo-intense lesion volume pre and post gadolinium (r=0.96, P50.001). However, the EDSS was not correlated with the T2 lesion load (r=70.27, P=0.2), T1 pre-gadolinium load (r=70.3, P=0.1), T1 post gadolinium load (r=70.4, P=0.7) and enhancing lesion load (r=70.28, P=0.2), or with the degree of hypointensity of T1 weighted images determined using the threshold technique. There is a strong correlation between T1 hypointense lesion volume both pre and post gadolinium and also between T1 and T2 lesion volumes.

Keywords

multiple sclerosis T1 hypointense lesion load

Get full access to this article

View all access options for this article.

References

Noseworthy JH et al. (1990) Interrater variability with the Expanded Disability Status Scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial . Neurology 40: 971-975 .

Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale . Neurology 33: 1444-1452 .

Young IR et al. (1981) Nuclear magnetic resonance imaging in the brain in multiple sclerosis . Lancet 2: 1063-1066 .

Stewart WA et al. (1984) Correlation between NMR and brain slice: data in multiple sclerosis . Lancet 2: 412-412 .

Thompson AJ et al. (1992) Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration . Neurology 42: 60-63 .

Thompson AJ et al. Commentin : BMJ 300: 1272-1272 .

Kidd D et al. (1993) Spinal cord MRI using multi-array coils and fast spin echo II. Findings in multiple sclerosis . Neurology 43: 2632-2637 .

The IFNB Multiple Sclerosis Study Group . Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicentre, randomised, double-blind, placebo-controlled trial . Neurology 43: 655-661 .

Paty DW , Li DKB. UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group . Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicentre, randomised, double-blind, placebo-controlled trial . Neurology 43: 662-667 .

10.

Jacobs LD et al. (1996) Intramuscular Interferon Beta-1a for disease progression in relapsing multiple sclerosis . Ann Neurol 39: 285-294 .

11.

Gass A et al. (1994) Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis . Ann Neurol 36: 62-67 .

12.

Arnold DL et al. (1994) Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis . Ann Neurol 36: 76-82 .

13.

Davie CA et al. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions . Brain 117: 59-58 .

14.

Filippi M et al. (1995) A spinal cord MRI study of benign and secondary progressive multiple sclerosis . In: Proceedings of The Society of Magnetic Resonance Third Scientific Meeting and Exhibition 1: 277-277 .

15.

Kidd D et al. (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis . J Neurol Neurosurg Psychiatry 60: 15-19 .

16.

Losseff NA et al. (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression . Brain 119: 701-708 .

17.

Truyen L et al. (1996) Accumulation of hypointense lesions (`black holes') on T1 spin echo MRI correlates with disease progression in multiple sclerosis . Neurology 47: 1469-1476 .

18.

van Walderveen MAA et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1 weighted) spin echo images . Neurology 45: 1684-1690 .

19.

van Walderveen MAA et al. (1996) Histopathologic correlates of hypointense lesions on T1 weighted SE MR images in multiple sclerosis . JNeurol (Suppl II): 242, 18-18

20.

Wicks DAG et al. (1992) Volume measurement of multiple sclerosis lesions with magnetic resonance images . Neuroradiol 34: 475-479 .

21.

Plummer D (1992) Dispimage: a display and analysis tool for medical images . Riv Neuroradiol 5: 227-231 .

22.

Grimaud J et al. (1996) Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer assisted techniques . Magn Reson Imaging 14: 495-505 .

23.

Barnes D et al. (1986) Magnetic resonance imaging of experimental cerebral oedema . J Neurol Neurosurg Psychiatry 49: 1341-1347 .

24.

Barnes D et al. (1988) The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging . Brain 111: 83-94 .

25.

Silver NC et al. (1997) Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis . Neuroradiol 39: 441-445 .